Medicated Skincare Market Report 2025

The medicated skincare market size has grown strongly in recent years. It will grow from $37.8 billion in 2024 to $40.42 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. During the historic period, growth was driven by higher disposable incomes, greater adoption of skincare routines by men, increased urban pollution affecting skin health, a growing elderly population with skin concerns, and a rising demand for multifunctional medicated skincare products.

The medicated skincare market size is expected to see strong growth in the next few years. It will grow to $52.27 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The growth expected during the forecast period is driven by the rising popularity of teledermatology consultations, ongoing innovations in active pharmaceutical ingredients, a growing consumer preference for clean and clinical skincare, the expansion of e-commerce in skincare distribution, and an increased emphasis on preventive dermatology solutions. Key trends anticipated in this period include progress in skin microbiome-focused therapies, the creation of AI-powered skin analysis tools, advancements in sustainable and eco-friendly formulations, improvements in personalized dermatological treatments, and the introduction of prescription-strength skincare products in retail channels.

The increasing prevalence of skin disorders is expected to drive growth in the medicated skincare market in the coming years. Skin disorders are medical conditions that impact the skin’s appearance, texture, or function, leading to problems like rashes, inflammation, infections, or chronic illnesses. This rise in skin disorders is largely due to elevated pollution levels in urban environments, where harmful pollutants penetrate the skin’s protective barrier, causing inflammation, accelerated aging, and a higher likelihood of conditions such as eczema, acne, and dermatitis. Medicated skincare products are effective for treating these disorders because they contain active ingredients that target underlying problems such as inflammation, irritation, or microbial imbalances. For example, according to the City of Hope, a US-based national cancer institute, melanoma accounts for 5.5% of all annual cancer diagnoses as of May 2023, with roughly 97,000 cases each year. By 2030, this number is projected to increase to 7.1%, totaling about 151,000 cases annually. Hence, the growing incidence of skin disorders is fueling the expansion of the medicated skincare market.

Leading companies in the medicated skincare industry are concentrating on launching innovative products such as regenerative skincare creams that speed up skin repair, reduce aging signs, enhance effectiveness, and promote healthier skin regeneration. Regenerative skincare creams are medicated formulations containing active ingredients like peptides and growth factors, which help repair damaged skin, stimulate cell regeneration, and restore a healthier, more youthful look. For instance, in May 2025, SkinCeuticals, a US-based skincare brand, introduced Advanced RGN-6, a regenerative skincare cream inspired by laser regeneration science. This product aims to visibly improve six major signs of aging and uneven skin tone, including redness, post-acne marks, dark spots, wrinkles, firmness loss, and reduced smoothness. Advanced RGN-6 combines six active ingredients, 10% Glyco-Repair, 1% Eperuline, 2% Niacinamide, 3% Acetyl Tetrapeptide-9, 0.2% Ectoin, and 0.2% Bioceramide 603, formulated to support both deep and surface-level skin repair. Clinical tests show that with regular daily use, the cream noticeably enhances skin texture and tone, producing visible results in as little as one week. Additionally, when used after laser treatments, it helps accelerate recovery by reducing downtime and improving skin hydration and smoothness.

In January 2025, Nykaa, an India-based retail and e-commerce company, partnered with Obagi Medical to introduce advanced dermatological products to the Indian market. This collaboration aims to provide Indian consumers with a wide range of world-class, clinically proven, medical-grade skincare products, empowering them with advanced, dermatologist-recommended treatments for various skin issues and raising the overall quality of skincare options available in the country. Obagi Medical, a US-based pharmaceutical firm, offers medicated skincare products, including prescription-strength formulas designed to address multiple skin concerns such as aging, hyperpigmentation, acne, and rosacea.

Major players in the medicated skincare market are Obagi Medical Products Inc., Murad LLC, Laboratoire Bioderma, Revision Skincare Inc., Innovative Skincare Inc., PCA Skin Inc., Sesderma S.L., SkinMedica Inc., Neocutis Inc., Zota Health Care Limited, Alastin Skincare Inc., Dr. Wu Cosmetic Enterprise Co. Ltd., ZO Skin Health Inc., Skinbetter Science LLC, Alna Biotech Private Ltd., Epionce Inc., SkinCeuticals Inc., Canbro Healthcare, Scot Derma Private Ltd., Vibcare Pharma Private Ltd., TiZO Products Inc., Stelon Biotech Private Ltd., and Hedge & Hedge Pharmaceutical.

North America was the largest region in the medicated skincare market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in medicated skincare report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the medicated skincare market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The medicated skincare market consists of sales of benzoyl peroxide, salicylic acid, clindamycin phosphate, azelaic acid, and hydrocortisone. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The medicated skincare market research report is one of a series of new reports that provides medicated skincare market statistics, including medicated skincare industry global market size, regional shares, competitors with a medicated skincare market share, detailed medicated skincare market segments, market trends and opportunities, and any further data you may need to thrive in the medicated skincare industry. This medicated skincare market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Medicated skincare involves products that are specially formulated to treat particular skin conditions like acne, eczema, rosacea, or psoriasis, going beyond basic cleansing or moisturizing. These products often contain clinically proven therapeutic ingredients and are commonly recommended by dermatologists to target and improve the health and appearance of affected skin areas.

The primary categories within medicated skincare include pharmaceutical-grade and prescription (Rx) products. Pharmaceutical-grade skincare meets rigorous purity, quality, and concentration standards suitable for medical or clinical use. It addresses a variety of skin conditions such as acne, psoriasis, eczema, and rosacea by incorporating ingredients like anti-inflammatories, antibacterials, antifungals, antioxidants, moisturizers, as well as synthetic, natural, organic, or chemical-based components. These products are available through dermatology clinics, online pharmacies, retail outlets, and come in various forms including creams, lotions, ointments, gels, and serums.

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.